Bronchitol to be Reimbursed in Australia
14th
Mar 12
Release Date: 14/03/2012 12:00am
Pharmaceutical company Pharmaxis is pleased to announce that its cystic fibrosis treatment Bronchitol has been recommended for listing on the Pharmaceutical Benefits Scheme (PBS) in Australia by the government’s expert advisory body the Pharmaceutical Benefits Advisory Committee (PBAC).
Categories: News and Media